Therefore, proposing this as a hypothetical without specification of age, first and foremost, limits the ability to extrapolate conclusions extensively. Is the person 70 with no history of events? Likely very mild difference? 30, with family history of ischemic events?
It is challenging to engage these types of arguments with data-driven follow up and analysis because terms and specifications are rarely provided. In exercises that are driven by cumulative statistics, which is exactly what this is, these sorts of specifications are **essential**
The response will, in all likelihood, be that individuals can be compared to age-matched controls across ages. However, this requires laborious assumptions. This requires assuming an exactly equivalent lipid profile throughout one’s entire life to extrapolate, which is
A dubious assumption based on any number of factors. Furthermore, it undermines the very nature of cumulative exposure metrics, which become extremely relevant in the case of a 30 year old with such a lipid panel.
Personally, a nuanced analysis of this likely requires several levels of stratification, especially looking at a genetic predisposition to atherosclerosis and ischemic events in the particular individuals. Even aside from that, though, asking completely out of context
With no critical analysis of data being used to make predictions is a false proposition, and I can lay out in immense detail why this sort of characterization is fraught with unaddressed limitations, despite attempts.
Anyway, good luck to all engaged parties. I would really like for the questions regarding extrapolation of the proposed but largely unstudied paradigms to be answered in a direct sense in a way that they have not been to date.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
So, this is indeed an interesting finding (though the linked does not provide access to the entire manuscript, which was hard to find), but it should be taken alongside the entirety of the LDL/Cancer relationship data.
A bit of background first-- LDL levels in the context of chronic disease are a bit tricky. (Chronic) Inflammatory conditions decrease LDL levels (via IL-6, TNFa, other cytokines), making it essential to consider the role of reverse causation in these types of analysis.
In the context of things like metabolic syndrome (which, remember, is also an inflammatory condition), this can be challenging, as there are forces pushing LDL in either direction. In cancer, though, it is a bit more clear cut--chronic inflammatory conditions decreases LDL levels